Clinical Comparison of Universal Adhesives in Terms of Different Application Modes on the Restoration of NCCLs

September 13, 2021 updated by: Dr. Fatma Dilşad Öz, Hacettepe University
The aim of this randomized, controlled, prospective clinical trial is to evaluate the performances of two different universal adhesives and an etch&rinse adhesive in restoration of non-caries cervical lesions. Twenty patients will receive restorations. Lesions will be divided into 7 groups according to adhesive systems and application modes: GSE: Gluma Universal- self etch, GSL: Gluma Universal-selective etching, GER: Gluma Universal-etch&rinse, ASE: All Bond Universal- self etch, ASL: All Bond Universal- selective etching, AER: All Bond Universal- etch&rinse, SB (Control): Single Bond2+etch&rinse. Restorations (nano-hybrid composite) will be scored with regard to retention, marginal discoloration, marginal adaptation, recurrent caries and post operative sensitivity using modified USPHS criteria after 48 months. Two examiners who is not involved in the placement of restorations will conduct the evaluations. Descriptive statistics will be performed using Chi-square tests.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Inclusion criteria will be as follows:

  1. being 18 years or older,
  2. having no medical or behavioral problems preventing then from attending review visits,
  3. having at least 7 tooth with NCCLs (d) having antagonist teeth.

Exclusion Criteria:

Exlusion criteria will be:

  1. poor gingival health,
  2. uncontrolled, rampant caries,
  3. bruxism,
  4. removable partial dentures,
  5. xerostomia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Gluma Universal, self-etch mode (GSE)
Adhesive systems
EXPERIMENTAL: Gluma Universal, selective etching (GSL)
Adhesive systems
EXPERIMENTAL: Gluma Universal, etch&rinse (GER)
Adhesive systems
EXPERIMENTAL: All Bond Universal, self-etch (ASE)
Adhesive systems
EXPERIMENTAL: All Bond Universal, selective etching (ASL)
Adhesive systems
EXPERIMENTAL: All Bond Universal, etch&rinse (AER)
Adhesive systems
EXPERIMENTAL: Single Bond2, etch&rinse (SBU)
Adhesive systems

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical performances of different adhesives
Time Frame: Two years
Two year examinations according to USPHS criteria
Two years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2015

Primary Completion (ACTUAL)

November 1, 2015

Study Completion (ACTUAL)

November 1, 2018

Study Registration Dates

First Submitted

December 23, 2017

First Submitted That Met QC Criteria

January 28, 2018

First Posted (ACTUAL)

January 30, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 14, 2021

Last Update Submitted That Met QC Criteria

September 13, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Universal Clinical NCCLs

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Wear

Clinical Trials on Gluma Universal

Subscribe